Patent US4708932A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4708932A Expired / Lapsed US ⏱️ 0.0 years remaining

Method and device for biospecific affinity reactions

Assignee: Phadia AB
•
Filing: 1984-02-02
•
Granted: 1987-11-24
•
Expires: 2004-02-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved process of performing analysis methods based upon biospecific affinity reactions in heterogeneous systems, wherein a ligand dissolved in a liquid is reacted with a receptor immobilized on a carrier, characterized by utilizing as the carrier a porous matrix in the form of a material body having an open capillary pore system capable of absorbing and retaining liquid phase and having such limited void dimensions that the total reaction rate of the biospecific reaction or reactions within the pore system between ligand and immobilized receptor will be at least substantially independent of the diffusion of the ligand in the liquid phase. A porous matrix for use in said process has the characteristics mentioned above.

Inventors

  • 👤 Rolf E. Axen
  • 👤 Goran L. Kaj
  • 👤 Rune Bjorkman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 11:03
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/544; G01N33/549; G01N33/54366; G01N33/54386; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S436/00; Y10S436/807

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 228 words
In a method of performing analyses based upon biospecific reactions in heterogeneous systems, comprising the steps of (a) providing a self-supporting carrier matrix body capable of absorbing and retaining liquid and having a first receptor component immobilized to the pore surfaces thereof, (b) sampling a predetermined volume of a liquid having dissolved therein a second ligand component that is to be determined, (c) contacting said predetermined sample volume with the matrix bocy to be completely absorbed and retained thereby, (d) permitting said first and second components to react to form an immobilized complex, and (e) detecting, and optionally quantitating the formation of said immobilized complex in said matrix, (f) the improvement comprising optimizing the total reaction rate of said second component with said first component by providing said first receptor component covalently bonded to the pore surfaces of said matrix in a sufficient amount for said total reaction rate to be dependent on the diffusion of said second component in the liquid phase, and by minimizing the influence of said diffusion by selecting the pore dimensions of said matrix body so that the total diffusion process therein substantially corresponds to that of a matrix having cylindrical pores with a diameter of less than about 200 μm, but sufficiently large to permit easy passage of the reagents, to thereby make said total reaction rate substantially independent of said diffusion.
Claim 2
Dependent Claim 228 words
In a method of performing analyses based upon biospecific reactions in heterogeneous systems, comprising the steps of (a) providing a self-supporting carrier matrix body capable of absorbing and retaining liquid and having a first receptor component immobilized to the pore surfaces thereof, (b) sampling a predetermined volume of a liquid having dissolved therein a second ligand component that is to be determined, (c) contacting said predetermined sample volume with the matrix bocy to be completely absorbed and retained thereby, (d) permitting said first and second components to react to form an immobilized complex, and (e) detecting, and optionally quantitating the formation of said immobilized complex in said matrix, (f) the improvement comprising optimizing the total reaction rate of said second component with said first component by providing said first receptor component covalently bonded to the pore surfaces of said matrix in a sufficient amount for said total reaction rate to be dependent on the diffusion of said second component in the liquid phase, and by minimizing the influence of said diffusion by selecting the pore dimensions of said matrix body so that the total diffusion process therein substantially corresponds to that of a matrix having cylindrical pores with a diameter of less than about 200 μm, but sufficiently large to permit easy passage of the reagents, to thereby make said total reaction rate substantially independent of said diffusion.
Claim 3
Dependent Claim 41 words
A method according to claim 1 wherein the pore dimensions of the carrier matrix is selected so that the total diffusion process therein corresponds to that of a matrix having cylindrical pores with a diameter of less than about 100 μm.
Claim 4
Dependent Claim 14 words
A method according to claim 1 wherein said carrier matrix body comprises a polysaccharide.
Claim 5
Dependent Claim 15 words
A method according to claim 1 wherein said carrier matrix body comprises a polysaccharide derivative.
Claim 6
Dependent Claim 15 words
A method according to claim 1 wherein said carrier matrix body comprises a cellulose material.
Claim 7
Dependent Claim 13 words
A method according to claim 1 wherein said carrier matrix body comprises agarose.
Claim 8
Dependent Claim 13 words
A method according to claim 1 wherein said carrier matrix body comprises dextran.
Claim 9
Dependent Claim 13 words
A method according to claim 1 wherein said carrier matrix body comprises startch.
Claim 10
Dependent Claim 14 words
A method according to claim 1 wherein said biospecific reaction s an immunochemical reaction.
Claim 11
Dependent Claim 24 words
A method according to claim 1 wherein the pore surfaces of the matrix body are coated with a surface-modifying layer of a different material.
Claim 12
Dependent Claim 14 words
A method according to claim 10 wherein said different material is a polymer layer.
Claim 13
Dependent Claim 19 words
A method according to claim 11 wherein the thickness of said polymer layer is less than about 15 μm.
Claim 14
Dependent Claim 29 words
A method accoridng to claim 1 whereinsaid detecting and optionally quantitating step comprises reacting said immobilized complex formed with a third component capable of reacting with said second component.

References Cited (Backward Citations)

US3376114A Cited
US3770383A Cited
GB1392912A Cited
US3951748A Cited
US4116638A Cited
US4278651A Cited
EP0013156A1 Cited
US4293536A Cited
EP0051183A1 Cited
US4540660A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-11-23 1991-05-25 1991-11-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-11-23 1995-05-25 1995-11-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-11-23 1999-05-25 1999-11-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag